Recurrent Severe Hypoglycemia in a 43 Year Old Extreme Obese Woman with Insulinoma: A Case Report
DOI:
https://doi.org/10.66266/inajemd.v2i2.66Abstract
Insulinomas are very rare neuroendocrine tumors (4 cases per million individuals per year) leading to insulin hypersecretion and occurring more often in women at any age. A 43 year old extreme obese woman was referred to Dr Kariadi General Hospital with complaints history of repeated
unconsciousness due to recurrent episodes of symptomatic severe hypoglycaemia (previously been hospitalized several times in regional hospitals in last six years). Physical examination: Body Mass Index Class II obesity (Asia-Pacific). Laboratory: recurrent hypoglycaemia (random blood glucose range 30-50 mg/dL), Fasting Blood Glucose 105 mg/dL (n: 80-109), 2 hours Postprandial Blood Glucose 44 mg/dL (n: 80- 140), C-peptide levels (taken during hypoglycaemia) 13.59 ng/ml (n:1.1-4.4). Abdominal Ultrasonography : grade 2 fatty liver, Fibroscan: no fibrosis or steatosis, Plain Head MSCT: no visible abnormalities, contrast abdominal magnetic resonance imaging: solid lesion in the body of pancreas (AP 1.2 x LL 1.2 x CC 1.3 cm) tends to be a picture of insulinoma. Patient underwent distal pancreatectomy with immunohistochemical results of an insulinoma. Post surgery the patient never had hypoglycaemia. We described a 43 year old extreme obese woman with recurrent episodes of symptomatic severe hypoglycaemia. Laboratory (low random blood glucose, high C-peptide) and imaging examinations (solid lesion in the body of the pancreas on
Contrast Abdominal MRI) support the diagnosis of insulinoma. Surgery is the treatment of choice for insulinomas. Patients with recurrent severe hypoglycemia, increase in C-peptide levels and solid lesion in pancreas are clinical manifestations of Insulinoma.
Downloads
References
1. Hofland J, Refardt JC, Feelders RA, Christ E, de W.
Approach to the Patient: Insulinoma. The Journal
of Clinical Endocrinology and Metabolism. 2023
Oct 31;Availablefrom:https://academic.oup.com/
jcem/article/109/4/1109/7334393#44367 2700
2. Wang T, Vu A, Mereu L, Ghosh M. Malignant
insulinoma in a patient with hypoglycemia. CMAJ.
2022 Mar 7 [cited 2023 Nov 23];194(9):E332–
5. Available from: https://www.cmaj.ca/
content/194/9/E332.short
3. Dimitrios Giannis, Moris D, Georgia Sofia
Karachaliou, Tsilimigras DI, Georgios Karaolanis,
Alexandros Papalampros, et al. Insulinomas: from
diagnosis to treatment. A review of the literature.
Journal of BUON : official journal of the Balkan
Union of Oncology. 2020 May 1;25(3):1302–14.
4. Hoskovec D, Z Krška, J Škrha, Pavol Klobušický,
Petr Dytrych. Diagnosis and Surgical Management
of Insulinomas—A 23-Year Single-Center
Experience. Medicina- lithuania [Internet].
2023 Aug 4 [cited 2023 Nov 23];59(8):1423–3.
Available from: https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC10456644/
5. Prídavková D, Samoš M, Kyčina R, Adamicová
K, Kalman M, Belicová M, et al. Insulinoma
presenting with postprandial hypoglycemia and
a low body mass index: A case report. World
Journal of Clinical Cases [Internet]. 2020 Sep
26;8(18):4169–76. Available from: https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC7520770/
Downloads
Published
Issue
Section
License
Copyright (c) 2025 InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD) the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
© Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD). Published by the Indonesian Society of Endocrinology (PERKENI).


